The Latest Breaking News from Lung Disease

Researchers say 55% of COPD patients suffering two or more acute attacks a year earn under £20,000, with the poorest five times more likely to die from the condition

The FDA has approved Beyond Air Inc's (NASDAQ:XAIR) LungFit PH to treat term and near-term neonates with hypoxic respiratory failure (often referred to as persistent pulmonary hypertension of the newborn or PPHN).  LungFit PH is the initial device from the LungFit therapeutic platform of nitric oxide generators. It is the first FDA-approved product…

Monday marks the start of Love You Lungs week, a campaign to raise awareness of lung health. A lung condition can be permanent but there are treatments to slow down progression.

Exercise to help COPD hospital patients is being rolled out across Kyrgyzstan and to neighbouring countries

Beyond Air Inc (NASDAQ:XAIR) announced new interim data from the ongoing LungFit GO pilot at-home study in Australia. In this study, patients self-administered high concentration inhaled nitric oxide (NO) at home to treat severe nontuberculous mycobacterial (NTM) lung disease.  These data were shared at the American Thoracic Society International Conference 2022.  The company…

The partnership between Chest Heart and Stroke Scotland and the NHS has been welcomed.

Up to 24 different types of respiratory conditions including asthma, sleep apnoea, and pneumonia are being supported through PIP

Anybody living with asthma has been urged to check if they are eligible for up to £128 a week from the UK Government through the Personal Independence Payment benefit.

There is a list of 24 respiratory conditions being supported through PIP

You could be owed money from the government

There has recently been an increase in the number of people now receiving support for 24 types of respiratory conditions